drugset / Trial / NCT00120744

Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department

NCT00120744

RandomizedParallel-groupDouble-blindPrevention

Summary

The objectives of the study were to determine whether ondansetron treatment would reduce: * the amount of vomiting in the emergency department; * the need for intravenous rehydration; and * the need for hospitalization.

Timeline

Start
2004-01
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified Oral